Author + information
- Manotosh Panja1
Coronary artery lesions are often long and tortuous necessitating overlapping stents during angioplasty. Indigenous Biomime MORPH tapering stents from Meril are a new alternative.
This prospective, observational study documents our experience with the use of Meril Biomine Morph stent in varied coronary anatomy and clinical scenarios and their clinical follow-up over six months.
Patients, in whom Biomime Morph stents were used, as were indicated during the procedure at our center during the period January to March 2016, were followed up clinically. Data regarding the stents, lesion anatomy and procedure details were tabulated and analyzed.
56 Biomime morph stents were implanted during the specified time in 52 patients. Of these, 64%, 7% and 29% were deployed in LAD, LCx and RCA respectively. Use in CTO lesions constituted 8 (14%) lesions. Mean stent length was 53.2 mm with 60 and 50 mm stents being used in 32% and 68% lesions respectively. Use of guidezilla to track the stents up to the lesions was required in only 6 (10.7%) lesions. There was no evidence of foreshortening on post-deployment IVUS study. No clinical events were recorded on a 9 month follow up.
Biomime Morph from Meril is a more anatomically acceptable and cost-effective option in diffuse or tandem coronary lesions. There is no question of overlapping stents. It requires less procedural time and provides good clinical outcomes. Ultimately large scale metacentric study with long-term follow-up is needed regarding its future.